Skip to main content
Conferences and Meetings 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

Short name: updated-203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II-2023
Course start date: 01/11/2026
Auto Enroll

Sections

General
0 activities

A Pan-Cancer Single-Cell Transcriptomic Atlas of Natural Killer (NK) Cells Reveals Intrinsic and Extrinsic Mediators of NK Cell Anti-Tumor Functions
Stroma-Driven Notch2 Signaling Controls Naïve B Cell Fate By Regulating Microenvironmental Positioning within the Spleen
Blockade of Common Gamma Chain Cytokine Signaling with REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody, in Combination with Cost
Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses
Evaluation of Safety and Efficacy of Ruxolitinib in Patients with Pediatric Lymphoproliferative Disorders
Human Cytomegalovirus Infection Promotes the Formation of NKG2CHi Memory NK Cells That Express Elevated Levels of IL-7R and Cyto-CD3e
Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China
MAIT Cell Proliferation Is a Potential Early Diagnosis Marker for Blood Stream Infection in AML Patients

Vimeo Vimeo
8